11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Farnesoid X receptor is essential for the survival of renal medullary collecting duct cells under hypertonic stress

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          As a ligand-activated transcription factor, farnesoid X receptor (FXR) is abundantly expressed in the liver and small intestine, where it plays an important role in the maintenance of bile acid, lipid, and glucose homeostasis. Increasing evidence is emerging that FXR may be a critical regulatory factor in renal physiology and pathophysiology. The present study demonstrates an essential role of FXR in promoting cell survival of medullary collecting duct cells under hypertonic stress and identifies FXR-induced TonEBP expression and activation as an underlying mechanism. This work provides an insight into the role of FXR in renal urine concentration.

          Abstract

          Hypertonicity in renal medulla is critical for the kidney to produce concentrated urine. Renal medullary cells have to survive high medullary osmolarity during antidiuresis. Previous study reported that farnesoid X receptor (FXR), a nuclear receptor transcription factor activated by endogenous bile acids, increases urine concentrating ability by up-regulating aquaporin 2 expression in medullary collecting duct cells (MCDs). However, whether FXR is also involved in the maintenance of cell survival of MCDs under dehydration condition and hypertonic stress remains largely unknown. In the present study, we demonstrate that 24-hours water restriction selectively up-regulated renal medullary expression of FXR with little MCD apoptosis in wild-type mice. In contrast, water deprivation caused a massive apoptosis of MCDs in both global FXR gene-deficient mice and collecting duct-specific FXR knockout mice. In vitro studies showed that hypertonicity significantly increased FXR and tonicity response enhancer binding protein (TonEBP) expression in mIMCD3 cell line and primary cultured MCDs. Activation and overexpression of FXR markedly increased cell viability and decreased cell apoptosis under hyperosmotic conditions. In addition, FXR can increase gene expression and nuclear translocation of TonEBP. We conclude that FXR protects MCDs from hypertonicity-induced cell injury very likely via increasing TonEBP expression and nuclear translocation. This study provides insights into the molecular mechanism by which FXR enhances urine concentration via maintaining cell viability of MCDs under hyperosmotic condition.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

          Mice lacking the nuclear bile acid receptor FXR/BAR developed normally and were outwardly identical to wild-type littermates. FXR/BAR null mice were distinguished from wild-type mice by elevated serum bile acid, cholesterol, and triglycerides, increased hepatic cholesterol and triglycerides, and a proatherogenic serum lipoprotein profile. FXR/BAR null mice also had reduced bile acid pools and reduced fecal bile acid excretion due to decreased expression of the major hepatic canalicular bile acid transport protein. Bile acid repression and induction of cholesterol 7alpha-hydroxylase and the ileal bile acid binding protein, respectively, did not occur in FXR/BAR null mice, establishing the regulatory role of FXR/BAR for the expression of these genes in vivo. These data demonstrate that FXR/BAR is critical for bile acid and lipid homeostasis by virtue of its role as an intracellular bile acid sensor.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Bile acids in glucose metabolism in health and disease

            Bile acids were recently shown to regulate glucose homeostasis through diverse mechanisms involving the host and its microbiome. Herein, Shapiro et al. discuss the impact of bile acids on normal and impaired glycemic responses, including potential therapeutic implications in treating hyperglycemia and diabetes.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption.

              Thiazolidinediones (TZDs) are widely used to treat type 2 diabetes mellitus; however, their use is complicated by systemic fluid retention. Along the nephron, the pharmacological target of TZDs, peroxisome proliferator-activated receptor-gamma (PPARgamma, encoded by Pparg), is most abundant in the collecting duct. Here we show that mice treated with TZDs experience early weight gain from increased total body water. Weight gain was blocked by the collecting duct-specific diuretic amiloride and was also prevented by deletion of Pparg from the collecting duct, using Pparg (flox/flox) mice. Deletion of collecting duct Pparg decreased renal Na(+) avidity and increased plasma aldosterone. Treating cultured collecting ducts with TZDs increased amiloride-sensitive Na(+) absorption and Scnn1g mRNA (encoding the epithelial Na(+) channel ENaCgamma) expression through a PPARgamma-dependent pathway. These studies identify Scnn1g as a PPARgamma target gene in the collecting duct. Activation of this pathway mediates fluid retention associated with TZDs, and suggests amiloride might provide a specific therapy.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc. Natl. Acad. Sci. U.S.A
                pnas
                pnas
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                22 May 2018
                8 May 2018
                : 115
                : 21
                : 5600-5605
                Affiliations
                [1] aAdvanced Institute for Medical Sciences, Dalian Medical University , Dalian, 116044 Liaoning, China;
                [2] bRenal Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104;
                [3] cDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Dalian Medical University , Dalian, 116044 Liaoning, China;
                [4] dCenter for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston , Houston, TX 77204;
                [5] eCenter for Biosciences, Department of Biosciences and Nutrition, Karolinska Institutet , Novum, 14186 Stockholm, Sweden
                Author notes
                2To whom correspondence may be addressed. Email: guanyf@ 123456dmu.edu.cn , jgustafs@ 123456central.uh.edu , or zhangxy@ 123456dmu.edu.cn .

                Contributed by Jan-Åke Gustafsson, April 10, 2018 (sent for review March 6, 2018; reviewed by Chuanming Hao and Baoxue Yang)

                Author contributions: Y.G., J.-Å.G., and X.Z. designed research; S.X., S.H., Z.L., T.C., Y.W., M.X., Y.L., C.D., and B.W. performed research; N.W., Y.G., and J.-Å.G. contributed new reagents/analytic tools; F.Z. and X.Z. analyzed data; and Y.G., J.-Å.G., and X.Z. wrote the paper.

                Reviewers: C.H., Fudan University; and B.Y., Peking University.

                1S.X., S.H., and Z.L. contributed equally to this work.

                Article
                PMC6003498 PMC6003498 6003498 201803945
                10.1073/pnas.1803945115
                6003498
                29739889
                54d23f9a-245f-435d-909a-7d3d8a50dfd6
                Copyright @ 2018

                Published under the PNAS license.

                History
                Page count
                Pages: 6
                Funding
                Funded by: National Natural Science Foundation of China (NSFC) 501100001809
                Award ID: 81570636/81722010/81390351/91639201
                Categories
                Biological Sciences
                Physiology

                osmoprotection,bile acid receptor,NFAT5,hypertonicity,cell viability

                Comments

                Comment on this article